Estamos mejorando nuestra Tienda, Portal de clientes y Aenormas para ofrecerte una mejor experiencia.
Si detectas cualquier incidencia o necesitas ayuda durante el proceso de compra, puedes contactarnos a través del chat o escribirnos a normas@aenor.com.
Nuestro equipo estará encantado de ayudarte.
DIN EN ISO 10993-1:2024-07
Biological evaluation of medical devices - Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process (ISO/DIS 10993-1:2024); German and English version prEN ISO 10993-1:2024 / Note: Date of issue 2024-06-21
| Fecha edición: |
2026-03-01
Anulada
|
|---|---|
| Fecha cancelación: | 2026-03-01 |
| Idiomas disponibles: | Alemán, Inglés |
| Resumen: | This document specifies requirements and general principles governing the biological evaluation of medical devices within a risk management process per ISO 14971. This document applies to the evaluation of medical devices that have direct contact or indirect contact with either: a patient's body during intended use or reasonably foreseeable misuse; or the body of other users who are not patients, if the medical device is intended for personal protection (e. g., medical gloves, masks). Biological evaluation assesses the biological safety of the medical device by considering the biological risks associated with: constituents of a medical device; and tissue-device interactions (including physical effects). The biological evaluation specified by this document can address the biological safety of the medical device throughout its life cycle from design and development through initial use of the finished medical device to final decommissioning or withdrawal from use. The evaluation considers both the biological safety of the finished device in first use, and the significance of any changes to the medical device which can occur throughout the life cycle. However, the evaluation of risks related to environmental impacts of decommissioning of medical devices are not within the scope of this document. This version of the standard does not mandate re-testing of medical devices that are already on the market and have established and acceptable safety profiles (see 6.6.2). This document can be useful to support clinical or usability evaluations of medical devices. For example, a biological evaluation is a pre-requisite for conduct of a clinical trial. This means that principles outlined by this standard can be applied to evaluation of prototype or development stage devices as well as to finished medical devices. Other parts of ISO 10993 cover specific aspects of biological evaluation such as chemical characterisation, biological testing, sample preparations, animal welfare and toxicological risk assessment. For some types of medical devices, specific requirements from other standards (outside the ISO 10993-series) can be considered with justification for the approach taken in the event of differences between ISO 10993 requirements and those provided in other standards. For example, the ISO 18562 series of standards provides specific requirements for biological evaluation of breathing gas pathway medical devices and ISO 7405 provides specific requirements for biological evaluation of dental devices. The evaluation of risks related to infectious agents (e. g., bacteria, moulds, yeasts, viruses, transmissible spongiform encephalopathy (TSE) agents) is not within the scope of this document. NOTE 1 The evaluation of bacterial endotoxins is addressed by ISO 11737-3. NOTE 2 Evaluation of risks related to viruses, TSE agents and other pathogens is addressed by the ISO 22442 series, which provide requirements for risk assessments for materials of animal origin. |
| Keywords: | Bioassay|Biocompatibility|Biological|Biological analysis and testing|Biological hazards|Biological tests|Categories|Classification|Compatibility|Definitions|Evaluations|Fine mechanics|Fitness for purpose|Human body|Implants (surgical)|Management systems|Medical devices|Medical equipment|Medical products|Medical sciences|Medical technology|Principles|Risk management|Safety|Selection|Specification (approval)|Surgical equipment|Testing|Use |
| ICS: | 11.100.20 - Evaluación biológica de productos sanitarios |
| CTN: | |
|
Reemplazo Normas |
Es reemplazada por DIN EN ISO 10993-1:2026-03 |










